LGVN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 22:00):

Stats
Dagens volum	336 983
Gjennomsnittsvolum	2.16M
Markedsverdi	9.74M
EPS	$0 ( 2024-02-27 )
Neste inntjeningsdato	( $-2.01 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.150
ATR14	$0.00700 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Locklear Lisa	Sell	410	Class A Common Stock
2024-05-02	Agafonova Nataliya	Sell	308	Class A Common Stock
2024-04-11	Hare Joshua	Buy	42 553	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Class A Common Stock
2024-04-10	Hare Joshua	Buy	106 383	Warrant (right to buy)

INSIDER POWER
39.69
Last 100 transactions
Buy: 1 179 927 \| Sell: 677 468

Volum Korrelasjon

Lang: -0.14 (neutral)

Kort: 0.10 (neutral)

Signal:(45.829) Neutral

Longeveron Inc. Class A Korrelasjon

10 Mest positive korrelasjoner
EVOK	0.972
VVOS	0.97
UXIN	0.968
CNSP	0.963
KXIN	0.962
AYLA	0.961
RIDE	0.961
AGRI	0.957
ASLE	0.957
BCAN	0.955

10 Mest negative korrelasjoner
BRIVU	-0.956
MSDA	-0.955
SGII	-0.947
RNLC	-0.947
KRUS	-0.944
STAY	-0.944
MASI	-0.941
TIOAU	-0.941
INBKZ	-0.94
ADTH	-0.939

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Longeveron Inc. Class A Korrelasjon - Valuta/Råvare

-0.15
( neutral )

0.17
( neutral )

0.00
( neutral )

-0.61
( weak negative )

-0.63
( weak negative )

Longeveron Inc. Class A Økonomi

Annual	2023
Omsetning:	$709 000
Bruttogevinst:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2023
Omsetning:	$709 000
Bruttogevinst:	$-725 000 (-102.26 %)
EPS:	$-9.85

FY	2022
Omsetning:	$1.22M
Bruttogevinst:	$497 000 (40.67 %)
EPS:	$-9.36

FY	2021
Omsetning:	$1.31M
Bruttogevinst:	$590 000 (45.18 %)
EPS:	$-0.897

Financial Reports:

No articles found.

Longeveron Inc. Class A

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Sanntidsoppdatering for Longeveron Inc. Class A [LGVN]

Upcoming Earnings Alert